Orexigen Therapeutics Inc (OTC Pink - No Information:OREXQ)

0.1899
Delayed Data
As of Apr 23
 +0.0391 / +25.93%
Today’s Change
0.09
Today|||52-Week Range
3.81
-85.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues13.9M19.1M23.4M18.9M
 
 
 
 
 
Cost of Goods Sold4.2M6.1M6.7M3.9M
 
 
 
 
 
Depreciation And Amortization2.0M2.1M2.1M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income7.7M11.0M14.5M12.9M
 
 
 
 
 
General Expenses48.7M63.4M55.8M36.1M
 
 
 
 
 
Research And Development6.7M8.2M7.5M5.8M
 
 
 
 
 
Total Operating Expenses54.8M71.6M64.6M42.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.9M-52.4M-41.3M-23.3M
 
 
 
 
 
Extraordinary Credit26.0M12.3M6.0M500.0K
 
 
 
 
 
Extraordinary Charge-2.0M-29.4M-700.0K-628.0K
 
 
 
 
 
Interest Expense On Debt2.0M1.2M863.0K794.0K
 
 
 
 
 
Other Expenses-5.6M1.5M6.3M3.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.5M-69.1M-30.5M-20.8M
 
 
 
 
 
Income Taxes-133.0K0.000.000.00
 
 
Net Income-24.6M-69.1M-30.5M-20.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.6M14.8M15.2M15.4M
 
 
 
 
 
Shares To Calculate EPS Diluted14.6M14.8M15.2M15.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.69-$4.67-$2.00-$1.35
 
 
 
 
 
EPS Diluted-$1.69-$4.67-$2.00-$1.35